Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07456462) titled 'Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica Resonance' on Feb. 24.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: IRCCS San Raffaele
Condition:
Alzheimer Dementia (AD)
Mild Cognitive Impairment (MCI)
Intervention:
Other: MRI assessment and blood sample collection
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 1, 2026
Target Sample Size: 50
Countries of Recruitment:
Italy
To know more, visit https://c...